Cytosorbents Corp (CTSO) stock
CTSONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$4.87−0.50 (-9.31%)
Close on Nov 13, 2026Market cap $306.04MP/E –Yield –
Cytosorbents cash
Cash and short-term investments held at the end of each period.
Cytosorbents's cash was $4.41M at Jun 30, 2026. For fiscal 2025 it was $6.25M, down 36.0% from the year before. Over ten years it grew -1.8% a year on average. The highest annual figure on record is $71.42M in fiscal 2020.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.25M | -36.0% |
| FY2024 | Dec 31, 2024 | $9.76M | -37.5% |
| FY2023 | Dec 31, 2023 | $15.62M | -34.5% |
| FY2022 | Dec 31, 2022 | $23.83M | -55.7% |
| FY2021 | Dec 31, 2021 | $53.83M | -24.6% |
| FY2020 | Dec 31, 2020 | $71.42M | +483.9% |
| FY2019 | Dec 31, 2019 | $12.23M | -45.3% |
| FY2018 | Dec 31, 2018 | $22.37M | +29.1% |
| FY2017 | Dec 31, 2017 | $17.32M | +230.2% |
| FY2016 | Dec 31, 2016 | $5.25M | -30.1% |
| FY2015 | Dec 31, 2015 | $7.51M | +35.3% |
| FY2014 | Dec 31, 2014 | $5.55M | +154.2% |
| FY2013 | Dec 31, 2013 | $2.18M | +26.2% |
| FY2012 | Dec 31, 2012 | $1.73M | +45.7% |
| FY2011 | Dec 31, 2011 | $1.19M | +12.4% |
| FY2010 | Dec 31, 2010 | $1.06M | -33.8% |
| FY2009 | Dec 31, 2009 | $1.60M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $4.41M | -56.8% |
| Q1 FY2026 | Mar 31, 2026 | $4.81M | -63.3% |
| Q4 FY2025 | Dec 31, 2025 | $6.25M | -36.0% |
| Q3 FY2025 | Sep 30, 2025 | $7.54M | -38.1% |
| Q2 FY2025 | Jun 30, 2025 | $10.20M | -31.7% |
| Q1 FY2025 | Mar 31, 2025 | $13.11M | +52.3% |
| Q4 FY2024 | Dec 31, 2024 | $9.76M | -37.5% |
| Q3 FY2024 | Sep 30, 2024 | $12.17M | +21.1% |
| Q2 FY2024 | Jun 30, 2024 | $14.94M | +0.7% |
| Q1 FY2024 | Mar 31, 2024 | $8.61M | -58.5% |
| Q4 FY2023 | Dec 31, 2023 | $15.62M | -34.5% |
| Q3 FY2023 | Sep 30, 2023 | $10.05M | -58.6% |
| Q2 FY2023 | Jun 30, 2023 | $14.84M | -53.4% |
| Q1 FY2023 | Mar 31, 2023 | $20.74M | -53.6% |
| Q4 FY2022 | Dec 31, 2022 | $23.83M | -55.7% |
| Q3 FY2022 | Sep 30, 2022 | $24.24M | -60.3% |
| Q2 FY2022 | Jun 30, 2022 | $31.85M | -51.5% |
| Q1 FY2022 | Mar 31, 2022 | $44.71M | -34.7% |
| Q4 FY2021 | Dec 31, 2021 | $53.83M | -24.6% |
| Q3 FY2021 | Sep 30, 2021 | $61.04M | -30.6% |
| Q2 FY2021 | Jun 30, 2021 | $65.61M | +86.8% |
| Q1 FY2021 | Mar 31, 2021 | $68.47M | +159.5% |
| Q4 FY2020 | Dec 31, 2020 | $71.42M | +483.9% |
| Q3 FY2020 | Sep 30, 2020 | $87.98M | +450.6% |
| Q2 FY2020 | Jun 30, 2020 | $35.11M | +114.9% |
| Q1 FY2020 | Mar 31, 2020 | $26.39M | +34.3% |
| Q4 FY2019 | Dec 31, 2019 | $12.23M | -45.3% |
| Q3 FY2019 | Sep 30, 2019 | $15.98M | -35.9% |
| Q2 FY2019 | Jun 30, 2019 | $16.34M | -35.4% |
| Q1 FY2019 | Mar 31, 2019 | $19.65M | -6.8% |
| Q4 FY2018 | Dec 31, 2018 | $22.37M | +29.1% |
| Q3 FY2018 | Sep 30, 2018 | $24.91M | +61.8% |
| Q2 FY2018 | Jun 30, 2018 | $25.28M | +54.1% |
| Q1 FY2018 | Mar 31, 2018 | $21.09M | +550.9% |
| Q4 FY2017 | Dec 31, 2017 | $17.32M | +230.2% |
| Q3 FY2017 | Sep 30, 2017 | $15.40M | +141.6% |
| Q2 FY2017 | Jun 30, 2017 | $16.40M | – |
| Q1 FY2017 | Mar 31, 2017 | $3.24M | – |
| Q4 FY2016 | Dec 31, 2016 | $5.25M | – |
| Q3 FY2016 | Sep 30, 2016 | $6.38M | – |
See a number that looks wrong?